Aspirin
- Generic Name
- Aspirin
- Brand Names
- Aggrenox, Alka-seltzer, Alka-seltzer Fruit Chews, Anacin, Arthriten Inflammatory Pain, Ascomp, Aspi-cor, Aspir-low, Bayer Aspirin, Bayer Womens, Bc Arthritis, Bc Original Formula, Bufferin, Duoplavin, Durlaza, Ecotrin, Ecpirin, Endodan Reformulated May 2009, Equagesic, Exaprin, Excedrin, Excedrin PM Triple Action, Fasprin, Fiorinal, Goody's Body Pain, Goody's Extra Strength, Goody's PM, Miniprin, Norgesic, Norgesic Forte, Orphengesic, Pamprin Max Formula, Robaxisal, ST. Joseph Aspirin, Stanback Headache Powder Reformulated Jan 2011, Trianal, Trianal C, Vanquish, Vazalore, Yosprala
- Drug Type
- Small Molecule
- Chemical Formula
- C9H8O4
- CAS Number
- 50-78-2
- Unique Ingredient Identifier
- R16CO5Y76E
- Background
Also known as Aspirin, acetylsalicylic acid (ASA) is a commonly used drug for the treatment of pain and fever due to various causes. Acetylsalicylic acid has both anti-inflammatory and antipyretic effects. This drug also inhibits platelet aggregation and is used in the prevention of blood clots stroke, and myocardial infarction (MI) .
...
- Indication
Pain, fever, and inflammation
...
- Associated Conditions
- Acute Coronary Syndrome (ACS), Anxiety, Atherothrombotic cerebral infarction, Cardiovascular Disease (CVD), Cardiovascular Events, Cardiovascular Mortality, Colorectal Adenomas, Colorectal Cancer, Common Cold, Coronary artery reocclusion, Death, Dyspeptic signs and symptoms, Fever, Flu caused by Influenza, Headache, Heterozygous Familial Hypercholesterolemia (HeFH), Inflammation, Juvenile Idiopathic Arthritis (JIA), Major Adverse Cardiovascular and Cerebrovascular Events (MACCE), Menstrual Pain, Migraine, Morbidity, Mucocutaneous Lymph Node Syndrome, Muscle Contraction, Myalgia, Myocardial Infarction, Myocardial Infarction (MI), first occurrence, Neuropathic Pain, Pain, Pain caused by Common Cold, Pain caused by Rheumatism, Pericarditis, Polycythemia Vera (PV), Pre-Eclampsia, Rheumatism, Rheumatoid Arthritis, Rhino Sinusitis, Severe Pain, Spondyloarthropathies, Stroke, Systemic Lupus Erythematosus, Tension Headache, Thromboembolism, Thrombosis, Toothache, Transient Ischemic Attack, Vascular Death, Venous Thromboembolism, Acute Inflammation, Articular inflammation, Atherothrombotic events, Death caused by Myocardial Infarction, Fever or influenza-like illness, Moderate Pain, Recurrent Ischemic Stroke
- Associated Therapies
- Anti-platelet Therapy, Hemodialysis Treatment, Secondary Prevention
Safety and Effectiveness of Early Aspirin Administration After Mitral Valve Repair
- First Posted Date
- 2024-12-18
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 384
- Registration Number
- NCT06738992
- Locations
- 🇨🇳
Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
Optimal PERioperative Antiplatelet Therapy Investigation ON Abdominal Surgery After Coronary Stent Implantation
Phase 4
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-12-09
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Kyoto University
- Target Recruit Count
- 1200
- Registration Number
- NCT06723145
Antiplatelet Therapy and Endothelial-stabilizing Agents in Cerebral Small Vessel Diseases
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2024-12-05
- Target Recruit Count
- 300
- Registration Number
- NCT06715007
- Locations
- 🇨🇳
the First affiliated hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Treatment with Aspirin Alone Versus Aspirin in Combination with Fondaparinux Before Early Coronary Assessment in Patients with Non-ST-Elevation Myocardial Infarction
Phase 4
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-11-28
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- University of Aarhus
- Target Recruit Count
- 5068
- Registration Number
- NCT06710184
- Locations
- 🇩🇰
Aarhus University Hospital, Department of Cardiology, Aarhus N, Denmark
ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography
Phase 4
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-11-06
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Jung-min Ahn
- Target Recruit Count
- 5000
- Registration Number
- NCT06676280
Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients with Assist Device
- First Posted Date
- 2024-10-23
- Last Posted Date
- 2024-10-23
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 128
- Registration Number
- NCT06655376
- Locations
- 🇺🇸
Columbia Irving Medical Center, New York, New York, United States
Clopidogrel Vs. Aspirin in Patients with S. Aureus Bacteremia
Phase 4
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-21
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- Todd C. Lee MD MPH FIDSA
- Target Recruit Count
- 300
- Registration Number
- NCT06650488
- Locations
- 🇨🇦
McGill University Health Centre (Royal Victoria Hospital and Montreal General Hospital), Montreal, Quebec, Canada
Clopidogrel Plus Aspirin in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPrime)
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-11
- Last Posted Date
- 2024-10-11
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 200
- Registration Number
- NCT06638151
- Locations
- 🇨🇦
University of Alberta Hospital, Edmonton, Alberta, Canada
Efficacy of Aspirin in Preventing Venous Thromboembolism
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2024-10-10
- Last Posted Date
- 2024-10-10
- Target Recruit Count
- 60
- Registration Number
- NCT06635317
- Locations
- 🇲🇽
ISSSTEP, Puebla, Mexico
Colonoscopy and Antiplatelet Therapy Trial
Phase 4
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-09-25
- Last Posted Date
- 2024-09-25
- Lead Sponsor
- Ochsner Health System
- Target Recruit Count
- 100
- Registration Number
- NCT06613191
- Locations
- 🇺🇸
Ochsner Health, New Orleans, Louisiana, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath